Key Takeaway
Complete Mounjaro dosage guide for 2026. Titration schedule, dose levels from 2.5 mg to 15 mg, what to expect at each dose, and how to work with your physician on adjustments.
The Mounjaro doses schedule starts with a simple principle: go slow. Tirzepatide uses a six-step dose escalation plan that begins at the 2.5 mg starting dose and can go up to 15 mg weekly. This gradual titration schedule gives your gastrointestinal system time to adjust, minimizes side effects, and helps your health care provider find the maintenance dose that delivers the best balance of weight loss and tolerability.
At FormBlends, we personalize every patient's dosing plan. While the standard titration schedule provides a framework, we adjust timing and target doses based on how each patient responds. This guide explains every dose level, what to expect, and how to work with your physician to improve your results.
Overview: The Six Mounjaro Dose Levels
Mounjaro (tirzepatide) is available in six dose strengths. Each is delivered as a once-weekly subcutaneous injection using a pre-filled Mounjaro pen:
| Dose | Pen Color (Brand) | Role |
|---|---|---|
| 2.5 mg | Purple | Starting dose (not therapeutic for weight loss) |
| 5 mg | Brown | First therapeutic dose |
| 7.5 mg | Green | Intermediate dose |
| 10 mg | Teal | Mid-range therapeutic dose |
| 12.5 mg | Gray | High therapeutic dose |
| 15 mg | Blue | Maximum maintenance dose |
The 2.5 mg starting dose exists purely for tolerability. It was not designed to produce significant weight loss. Think of it as the onboarding phase where your body gets used to the medication's effects on gastric motility and appetite signaling.
The Standard Titration Schedule
The Mounjaro titration schedule follows a predictable dose escalation pattern. Each step lasts a minimum of four weeks: For a complete cost breakdown, see our best tirzepatide compounding pharmacies.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
| Weeks | Dose | Expected Changes |
|---|---|---|
| Weeks 1 to 4 | 2.5 mg | Mild appetite changes, minimal weight loss (1 to 3 lbs), body adjusting |
| Weeks 5 to 8 | 5 mg | Appetite noticeably reduced, weight loss begins (1 to 2 lbs/week), possible GI effects |
| Weeks 9 to 12 | 7.5 mg | Stronger appetite suppression, steady weight loss, food noise quieting |
| Weeks 13 to 16 | 10 mg | Significant appetite reduction, consistent 1.5 to 2.5 lbs/week loss typical |
| Weeks 17 to 20 | 12.5 mg | Strong therapeutic effect, approaching maximum benefit |
| Week 21 onward | 15 mg | Maximum dose, peak weight loss effect |
Each dose escalation happens at minimum four-week intervals. This is the fastest recommended pace. Your health care provider may extend any step to 6, 8, or even 12 weeks based on your response and side effect profile.
What Happens at Each Dose Level
2.5 mg: The Starting Dose Phase
This is your body's introduction to tirzepatide. Some patients feel almost nothing at this dose. Others notice a subtle reduction in hunger, slight changes in digestion, and perhaps mild nausea.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Weight loss is minimal, typically 1 to 3 pounds over the first month. Don't be discouraged. The starting dose is accomplishing exactly what it's supposed to: preparing your system for higher, more effective doses.
5 mg: The First Therapeutic Dose
Most patients notice a meaningful change at 5 mg. Appetite reduction becomes more pronounced. Portion sizes naturally shrink. Food cravings, particularly for high-calorie and processed foods, often start to diminish.
This is typically where patients first report that "food noise" has quieted. Weight loss of 4 to 8 pounds over this four-week period is common. GI side effects may flare for the first week after the increase.
7.5 mg: Building Momentum
Weight loss accelerates for many patients at 7.5 mg. Appetite suppression is consistent and noticeable. Patients often report needing conscious effort to eat enough protein and nutrients because hunger signals are so much quieter.
By the end of 12 weeks on the medication, many patients have lost 8% to 15% of their starting weight.
10 mg: The Sweet Spot for Many Patients
In clinical trials, the 10 mg maintenance dose produced an average weight loss of 19.5% over 72 weeks. For many patients, this dose offers an excellent balance of efficacy and tolerability.
Some patients find that increasing beyond 10 mg provides diminishing returns for additional weight loss relative to the increase in side effects. Your health care provider will help you evaluate whether moving higher makes sense for your situation.
12.5 mg: Approaching Maximum
Patients who continue the dose escalation past 10 mg are typically those who have tolerated lower doses well and still have significant weight to lose. Appetite suppression is very strong at this level. Careful attention to protein intake and nutrition becomes especially important to preserve lean muscle mass.
15 mg: The Maximum Maintenance Dose
The 15 mg dose produced the headline results from SURMOUNT-1[1]: 22.5% average weight loss at 72 weeks, with 57% of participants losing 20% or more of their body weight.
Not every patient needs to reach this dose, and not every patient tolerates it well. But for those who do, the weight loss results are the strongest available from any non-surgical intervention as of 2026.
Customizing Your Titration Schedule
Slowing Down the Dose Escalation
If you experience significant side effects at any dose level, your health care provider may recommend:
- Staying at the current dose for an additional 4 weeks before increasing
- Stepping back to a lower dose temporarily
- Increasing by smaller increments if using compounded tirzepatide (which allows more granular dose adjustments)
Stopping Below Maximum Dose
There's no requirement to reach 15 mg. If you're achieving good weight loss and tolerating a lower maintenance dose well, your physician may recommend staying there. Some patients achieve their goals at 7.5 mg or 10 mg and never need to go higher.
Dose Adjustments with Compounded Tirzepatide
One advantage of compounded tirzepatide (available through programs like FormBlends) is the ability to customize doses more precisely. Instead of jumping from 5 mg directly to 7.5 mg, a compounding pharmacy can prepare intermediate doses like 6 mg or 8 mg. This can help patients who are sensitive to dose changes titrate more gradually.
Injection Site Selection and Administration
When to Inject
- Administer the subcutaneous injection once weekly, on the same day each week
- You can choose any day that fits your schedule
- If you need to change your injection day, ensure at least 72 hours (3 days) have passed since your last dose
- Morning, afternoon, or evening injections are all acceptable. Some patients prefer evening injections so that any nausea peaks while they sleep
Choosing an Injection Site
Rotate your injection site each week. The three recommended areas for subcutaneous injection are:
- Abdomen: At least 2 inches from the navel. This is the most common injection site.
- Front of the thigh: Mid-thigh area
- Upper arm: Back of the upper arm (may need assistance)
Avoid injecting into the same exact spot consecutively. Rotating the injection site helps prevent skin irritation or lipodystrophy (changes in fat tissue at the injection site).
Missed Doses
If you miss a dose and fewer than 4 days (96 hours) have passed since the scheduled Mounjaro injection, take it as soon as you remember. If more than 4 days have passed, skip the missed dose and take the next one on your regular schedule. Don't double up on doses. For a complete breakdown of what to expect and when to call your provider, see our guide on missing a dose of Mounjaro or Zepbound.
Dosing for Specific Situations
Patients with Type 2 Diabetes
The titration schedule is the same regardless of whether you're using tirzepatide for diabetes or weight management. Patients on insulin or sulfonylureas may need dose reductions of those medications as tirzepatide improves blood sugar control. Monitor blood glucose closely, especially during the first weeks at each new tirzepatide dose.
Patients with Kidney or Liver Issues
No dose adjustment is required for mild to moderate kidney or liver impairment. Tirzepatide hasn't been extensively studied in patients with severe renal or hepatic impairment, so extra caution and monitoring from your health care provider are warranted.
Older Adults
No dose adjustment is needed based on age alone. Older adults may be more susceptible to dehydration from GI side effects. Extra attention to hydration and a potentially slower titration schedule may be appropriate.
How the Mounjaro Doses Schedule Affects Weight Loss Results
| Maintenance Dose | Average Weight Loss (SURMOUNT-1, 72 weeks) | Percent Losing 10%+ Body Weight |
|---|---|---|
| 5 mg | 15.0% | 69% |
| 10 mg | 19.5% | 82% |
| 15 mg | 22.5% | 89% |
There's a clear dose-response relationship. Higher doses produce greater weight loss on average. But even the lowest therapeutic dose (5 mg) produced 15% average weight loss, which is a medically significant result by any standard.
Frequently Asked Questions
What if I feel fine on a lower dose? Do I still need to increase?
Not necessarily. If you're losing weight at a satisfactory pace and tolerating your current dose well, your health care provider may recommend staying there. The goal is to find the lowest effective maintenance dose for your needs, not to automatically push to the maximum.
Can I skip a dose level in the titration schedule?
Eli Lilly's prescribing information recommends following the sequential dose escalation from 2.5 mg upward. Skipping dose levels is generally not recommended, as it increases the risk of GI side effects. Your physician can make clinical decisions based on your individual response.
How long does the full titration take?
Following the standard Mounjaro doses schedule (4 weeks at each level), reaching 15 mg takes approximately 20 weeks (about 5 months). If your physician slows the titration due to side effects, it may take longer.
What if I have side effects every time I increase?
Some GI effects during dose escalation are normal and expected. If they're mild and resolve within 1 to 2 weeks, that's a typical response. If they're severe or persistent, your health care provider may slow the titration, hold your current dose longer, or consider whether a different medication might be more appropriate.
Is there a difference in dosing between brand Mounjaro and compounded tirzepatide?
The active ingredient is the same. The titration schedule follows the same principles. One advantage of compounded formulations is the ability to create custom intermediate doses (like 3.5 mg or 6 mg) that aren't available in the brand pre-filled Mounjaro pen. This can help with a more gradual dose escalation.
What dose do most patients end up on?
This varies. In our clinical experience, a significant number of patients achieve their goals at 10 mg. Some need 12.5 mg or 15 mg. A smaller number do well at 5 mg or 7.5 mg. The right maintenance dose is the one that produces meaningful weight loss with acceptable side effects for you specifically.
Medical References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
Getting Started with FormBlends
Dosing is one of the most important aspects of successful tirzepatide treatment, and it isn't something you should find alone. Our physicians at FormBlends create individualized dosing plans, monitor your response at each level, and make adjustments based on your specific experience rather than following a one-size-fits-all protocol.
Start your free online assessment today to connect with a licensed physician and develop a personalized Mounjaro doses schedule.